N' alkylamine low molecular mass heparins (LMM-heparin-tyramine and LMM-heparin-tyramine-fitc) exhibit long lasting anticoagulant effects

By Malsch R.   Piazolo L.   Harenberg J.   Heene D.L.  

Thrombosis Research, Vol. 80, Iss. 3, 1995-11 ,pp. : 235-246

Elsevier

Access to resources Recommend Favorite

In-Vitro and Ex-Vivo Neutralizing Effect of Protamine Sulphate on the Anticoagulant Activity of a New Low Molecular Mass Heparin - a review of its toxicity

By Falkon L.   Gar M.   Gich I.   Fontcuberta J.  

Thrombosis Research, Vol. 89, Iss. 2, 1998-01 ,pp. : 79-83

Elsevier

Access to resources Recommend Favorite

A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents

By Mahan Charles  

Journal of Thrombosis and Thrombolysis, Vol. 37, Iss. 3, 2014-04 ,pp. : 271-278

Springer Publishing Company

Access to resources Recommend Favorite

Dextran sulfate included in factor Xa assay reagent overestimates heparin activity in patients after heparin reversal by protamine

By Mouton C.   Calderon J.   Janvier G.   Vergnes M.-C.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 273-279

Elsevier

Access to resources Recommend Favorite

Using low molecular weight heparin in special patient populations

By Lim Wendy  

Journal of Thrombosis and Thrombolysis, Vol. 29, Iss. 2, 2010-02 ,pp. : 233-240

Springer Publishing Company

Access to resources Recommend Favorite